GlassScriptPhysician profile
Paul B Hearn
NPI 1356326607
$7,635.05
in general payments reported to CMS, 2019-2025
16 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $955 · 2020: $325 · 2021: $2,467 · 2022: $2,769 · 2023: $617 · 2024: $263 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,119.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $3,356.78 | 2019-2025 | Acuvue |
| Coopervision INC. | $1,867.45 | 2019-2025 | Misight Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $1,446.04 | 2019-2024 | Total30, Dailies Total1 |
| Optos, INC. | $207.89 | 2019 | |
| Bausch & Lomb Americas INC. | $143.38 | 2023-2025 | Infuse, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $142.15 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $133.70 | 2019 | |
| Glaukos Corporation | $87.53 | 2020 | |
| Eyevance Pharmaceuticals LLC | $73.20 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $57.71 | 2019-2022 | |
| Biotissue Holdings INC. | $24.09 | 2019 | |
| Maculogix, INC. | $24.00 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $22.49 | 2022 | |
| Dompe US, INC. | $17.85 | 2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $15.98 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $14.81 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Hearn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.